One of the most comprehensive studies on Active Surveillance is the Miami Active Surveillance Trial (MAST), designed at the University of Miami. MAST has contributed significantly to understanding the safety and effectiveness of Active Surveillance, providing valuable insights into optimal monitoring protocols and patient selection criteria. This trial underscores the importance of a structured and evidence-based approach to Active Surveillance, ensuring that patients receive the best possible care.

By choosing Active Surveillance, you’re opting for a proactive, patient-centered strategy that balances cancer management with quality of life. Always discuss your options with your healthcare provider to determine if AS is the right choice for you.